Skin disease in dermatomyositis

Goreshi, 2011, Quality of life in dermatomyositis., J Am Acad Dermatol, 65, 1107, 10.1016/j.jaad.2010.10.016

Shrestha, 2010, Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells., Arthritis Rheum, 62, 2813, 10.1002/art.27529

Grassi, 2009, Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis., Clin Exp Dermatol, 34, 910, 10.1111/j.1365-2230.2009.03297.x

Torchia, 2010, The FasFas ligand system, rather than granzyme B, may represent the main mediator of epidermal apoptosis in dermatomyositis., Clin Exp Dermatol, 35, 669, 10.1111/j.1365-2230.2010.03808.x

Antiga, 2010, Characterization of regulatory T cells in patients with dermatomyositis., J Autoimmun, 35, 342, 10.1016/j.jaut.2010.07.006

Magro, 2010, The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis., J Cutan Pathol, 37, 659, 10.1111/j.1600-0560.2009.01443.x

Wong, 2012, Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases., PloS one, 7, e29161, 10.1371/journal.pone.0029161

Nabatian, 2012, Tumor necrosis factor alpha release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients., Arthritis Res Ther, 14, R1, 10.1186/ar3549

Zahn, 2011, Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus., J Invest Dermatol, 131, 133, 10.1038/jid.2010.244

Kim, 2011, Identification of specific chondroitin sulfate species in cutaneous autoimmune disease., J Histochem Cytochem, 59, 780, 10.1369/0022155411411304

Ogata, 2012, The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis., Biochem Biophys Res Commun, 418, 494, 10.1016/j.bbrc.2012.01.052

Kim, 2012, Gottrons papules exhibit dermal accumulation of CD44 Variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature., J Invest Dermatol, 132, 1825, 10.1038/jid.2012.54

Bendewald, 2010, Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota., Arch Dermatol, 146, 26, 10.1001/archdermatol.2009.328

Azuma, 2011, Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis., Mod Rheumatol, 21, 178, 10.3109/s10165-010-0362-y

Lofgren, 2011, Juvenile dermatomyositis presenting as an acquired inflammatory Blaschko-linear dermatosis., J Am Acad Dermatol, 65, e134, 10.1016/j.jaad.2011.05.044

Takahashi, 2010, A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis Allergol I, nt, 59, 425

Fiorentino, 2011, The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study., J Am Acad Dermatol, 65, 25, 10.1016/j.jaad.2010.09.016

Ikeda, 2011, Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients., J Dermatol, 38, 973, 10.1111/j.1346-8138.2011.01262.x

Ceribelli, 2012, Anti-MJNXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositisdermatomyositis., Arthritis Res Ther, 14, R97, 10.1186/ar3822

Gunawardena, 2009, Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis., Arthritis Rheum, 60, 1807, 10.1002/art.24547

Morganroth, 2010, Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations., Arch Dermatol, 146, 729, 10.1001/archdermatol.2010.134

Yamasaki, 2011, Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan., J Rheumatol, 38, 1636, 10.3899/jrheum.101002

Goreshi, 2012, Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM., J Invest Dermatol, 132, 1117, 10.1038/jid.2011.440

Mugii, 2011, Association between nail-fold capillary findings and disease activity in dermatomyositis., Rheumatology, 50, 1091, 10.1093/rheumatology/keq430

Ostrowski, 2010, Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis., Arthritis Rheum, 62, 1533, 10.1002/art.27379

Schmeling, 2011, Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis., Rheumatology, 50, 885, 10.1093/rheumatology/keq407

Hornung, 2012, Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions., Clin Exp Dermatol, 37, 139, 10.1111/j.1365-2230.2011.04188.x

Rouster-Stevens, 2010, Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis., Arthritis Care Res, 62, 1446, 10.1002/acr.20269

Dagher, 2012, Mycophenolate mofetil in juvenile dermatomyositis: a case series., Rheumatol Int, 32, 711, 10.1007/s00296-010-1653-5

Kampylafka, 2012, The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study., Clin Exp Rheumatol, 30, 397

Bader-Meunier, 2011, Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French autoimmunity and rituximab registry., J Rheumatol, 38, 1436, 10.3899/jrheum.101321

Amato, 2011, A randomized, pilot trial of etanercept in dermatomyositis., Ann Neurol, 70, 427, 10.1002/ana.22477

Balin, 2012, Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009., Arch Dermatology, 148, 455, 10.1001/archdermatol.2011.2052

Marco Puche, 2010, Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis., Clin Exp Rheumatol, 28, 135

Mori, 2012, Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy., J Bone Miner Metab, 30, 114, 10.1007/s00774-011-0289-1

Miyamae, 2003, Multicenter analysis of calcinosis in children with juvenile dermatomyositis., Ryumachi, 43, 538

Arabshahi, 2012, Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis., J Pediatr, 160, 520, 10.1016/j.jpeds.2011.11.057